Skip to contentSkip to main content

Sleep timing, jet lag and safety · Evidence guide

Melatonin: evidence-based dose, timing, benefits and safety

Melatonin can help selected circadian-timing problems and jet lag when it is taken at the right clock time.

It is not a strong general treatment for chronic insomnia: average adult effects are small, guidelines disagree by formulation and age, and CBT-I remains first-line. Start with the purpose and timing—not the biggest dose. Children, pregnancy, long-term nightly use, interacting medicines and inaccurate gummies deserve extra caution.1,2,3,4,5,8,9,11,13,23,34,35

Strong
Updated August 10, 202639 min readHuman evidence first
Unbranded pale melatonin tablet beside a translucent circadian clock and moon arc on cream and deep navy surfaces with bright LongevityMate orange highlights

At a glance

Melatonin

Overall evidence
Best for circadian timing and jet lag; small and inconsistent for general chronic insomnia1,2,4,5,8,9,10StrongFinding: mixed results
Jet lag
0.5–5 mg near destination bedtime was studied; wrong timing can worsen adaptation5,35ModerateFinding: benefit supported
Delayed sleep phase
0.5 mg plus a fixed schedule improved sleep onset in one clinical RCT; timing is specialist-led4,6,7ModerateFinding: benefit supported
Chronic insomnia
CBT-I first; fast-release melatonin is not routinely recommended1,2,3,9,10StrongFinding: no meaningful benefit
Age 55 and older
Regulated 2 mg prolonged release has a short-term European indication; dementia and daytime drowsiness need extra caution2,9,17,18,35ModerateFinding: small benefit
Best-supported form
Immediate release for clock shifting; regulated 2 mg prolonged release for its older-adult indication2,4,5,6,17,18ModerateFinding: mixed results
Children
Behavioral and medical causes first; use only with a clinician and reliable product11,12,13,21,22,34StrongFinding: mixed results
Long-term safety
Not established for routine nightly self-use, especially at high dose13,14,15,16,35StrongFinding: still unknown
US product accuracy
In a 25-product gummy assay, 22 were inaccurately labelled; content ranged from 74% to 347% and one had no detectable melatonin23,24StrongFinding: established use
Reassessment
Track the target for 1–4 weeks; prolonged-release plans should not drift past the reviewed duration2,5,6,17,18,20ModerateFinding: benefit supported

Study findings describe groups, not a guaranteed result for one person.

Research and writing

LongevityMate Editorial Team

Editorial oversight

Lukas Dvorsky, Founder

Clinical review

Not yet assigned or claimed